Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
ConclusionsIn this study, we found that maternal GBS vaccination could have a large impact on infant morbidity and mortality. Globally, a GBS maternal vaccine at reasonable prices is likely to be a cost-effective intervention.
Source: PLoS Medicine - Category: Internal Medicine Authors: Simon R. Procter Source Type: research
More News: Brain | Disability | Group B Streptococcus | Healthcare Costs | Internal Medicine | Legislation | Men | Meningitis | Meningitis Vaccine | Neurology | Pregnancy | Study | Vaccines | Women